Figure 1From: I-131-Metaiodobenzylguanidine therapy with allogeneic cord blood stem cell transplantation for recurrent neuroblastoma123I-MIBG scintigrams taken before (A) and after (B)131I-MIBG treatment with allo-CBSCT .123I-MIBG accumulation decreased after treatment in the parietal bone and humerus (black arrows), but it was still detected in the thoracic vertebrae and femur (white arrows).Back to article page